Anesthesia and Intensive Care Medicine, Department of Clinical and Surgical Translational Medicine, Sant' Andrea Hospital, Sapienza University of Rome, Rome, Italy.
Thoracic Surgery, Department of Clinical and Surgical Translational Medicine, Sant' Andrea Hospital, Sapienza University of Rome, Rome, Italy.
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3203-3210. doi: 10.1053/j.jvca.2020.05.042. Epub 2020 Jun 7.
Coronavirus disease 2019 (COVID-19) has quickly spread globally, causing a real pandemic. In this critical scenario, lung cancer patients scheduled for surgical treatment need to continue to receive optimal care while protecting them from an eventual severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Adequate use of personal protective equipment (PPE) during aerosol-generating procedures (AGPs) and a COVID-19 specific intraoperative management are paramount in order to prevent cross infections. New suggestions or improvement of existing contagion control guidance are needed, even in case of non-symptomatic patients, possibly responsible for virus spread.
2019 年冠状病毒病(COVID-19)迅速在全球范围内传播,引发了真正的大流行。在这种危急情况下,计划接受手术治疗的肺癌患者需要在保护他们免受严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染的同时,继续接受最佳护理。在产生气溶胶的程序(AGP)中充分使用个人防护设备(PPE)和 COVID-19 特定的术中管理对于防止交叉感染至关重要。即使是非症状患者,也可能导致病毒传播,因此需要提出新的建议或改进现有的传染病控制指南。